Header Image 01
Header Image 02
Header Image 03
Header Image 04
Header Image 05
Header Image 06
Header Image 07


The overall objective of the integrated work programme is to use existing biobanked samples and dietary and phenotype data from cohort studies and randomized controlled dietary intervention trials to:

  • identify novel FA and lipidomics biomarkers of cardiometabolic health which could replace or complement ‘established’ FA profiles as more sensitive biomarkers of status and of future cardiometabolic disease events,
  • establish relationships between whole diets and specific foods with tissue status of FA as explanatory factors for how diet relates to cardiometabolic health and
  • investigate genetic determinants of FA status and metabolism which may modify the effects of dietary intake.



H1: FA metabolites are novel biomarkers of cardiometabolic health.

H2: Odd-numbered SFA and trans-FA, are a valid biomarker of dairy fat intake and confer a benefit on intermediate health markers and reduction in cardiometabolic related conditions. 

H3: FA status may be modulated in an intake independent fashion, e.g. by the intake of plant-derived bioactives from whole diets.

H4: Genetic variants in PUFA elongation, desaturation and oxygenation genes modify dietary effects on PUFA status and health outcomes.